Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 39 in last 24h · 115,255 total before filter · latest 2h ago

39last 24h

1801last 7d

299● bullish (7d)

170● bearish (7d)

205publishers

All Macro322 Earnings850 M&A104 Regulatory25 Product16 Analyst25

✕ clear all filtersticker: GENBsentiment: bullishSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Insider Monkey117d agobullish

H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating

Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the best low priced biotech stocks to invest in. On April 13, H.C. Wainwright initiated coverage of Generate Biomedicines, Inc. (NASDAQ:GENB) with a Buy rating, setting a $16 price target. The firm told investors in a research note that the stock has fallen over 20% even as GB-0895 advanced into […]

GENB